MediciNova, Inc. (MNOV)
1.45
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 11:29
MediciNova SG&A Expense (TTM) : 6.780M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.780M |
| March 31, 2026 | 6.387M |
| December 31, 2025 | 6.159M |
| September 30, 2025 | 5.882M |
| June 30, 2025 | 5.525M |
| March 31, 2025 | 5.489M |
| December 31, 2024 | 5.481M |
| September 30, 2024 | 5.044M |
| June 30, 2024 | 4.946M |
| March 31, 2024 | 5.110M |
| December 31, 2023 | 5.242M |
| September 30, 2023 | 5.622M |
| June 30, 2023 | 5.713M |
| March 31, 2023 | 5.673M |
| December 31, 2022 | 5.485M |
| September 30, 2022 | 4.592M |
| June 30, 2022 | 4.700M |
| March 31, 2022 | 4.957M |
| December 31, 2021 | 5.715M |
| September 30, 2021 | 6.606M |
| June 30, 2021 | 6.547M |
| March 31, 2021 | 7.076M |
| December 31, 2020 | 6.694M |
| September 30, 2020 | 5.872M |
| June 30, 2020 | 5.875M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.280M |
| December 31, 2019 | 7.952M |
| September 30, 2019 | 7.834M |
| June 30, 2019 | 11.00M |
| March 31, 2019 | 10.30M |
| December 31, 2018 | 9.961M |
| September 30, 2018 | 11.93M |
| June 30, 2018 | 9.798M |
| March 31, 2018 | 9.685M |
| December 31, 2017 | 8.803M |
| September 30, 2017 | 7.403M |
| June 30, 2017 | 6.835M |
| March 31, 2017 | 7.169M |
| December 31, 2016 | 7.363M |
| September 30, 2016 | 8.336M |
| June 30, 2016 | 7.388M |
| March 31, 2016 | 6.626M |
| December 31, 2015 | 5.805M |
| September 30, 2015 | 5.583M |
| June 30, 2015 | 6.027M |
| March 31, 2015 | 5.843M |
| December 31, 2014 | 5.963M |
| September 30, 2014 | 5.998M |
| June 30, 2014 | 6.003M |
| March 31, 2014 | 6.549M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Viking Therapeutics, Inc. | 50.70M |
| IDEAYA Biosciences, Inc. | 77.07M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |